Erste Group analyst Hans Engel upgraded AstraZeneca (NASDAQ: AZN) from Hold to Buy.The analyst comments "AstraZeneca is a company with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE